Infection prevention and control measures for multidrug-resistant organisms: a systematic review and network meta-analysis

被引:0
|
作者
Geng, Yuhui [1 ]
Liu, Zhuo [1 ]
Ma, Xiaojuan [1 ]
Pan, Ting [1 ]
Chen, Mingbo [1 ]
Dang, Jingxia [1 ]
Zhang, Ping [1 ]
Chen, Chen [4 ]
Zhao, Yuan [4 ]
Pan, Dongfeng [3 ]
Liang, Peifeng [2 ]
机构
[1] Ningxia Med Univ, Sch Publ Hlth, Yinchuan, Peoples R China
[2] NingXia Med Univ, Peoples Hosp Ningxia Hui Autonomous Reg, Dept Med Affairs, Yinchuan, Peoples R China
[3] Ningxia Med Univ, Peoples Hosp Ningxia Hui Autonomous Reg, Dept Emergency Med, Yinchuan, Peoples R China
[4] Ningxia Med Univ, Peoples Hosp Ningxia Hui Autonomous Reg, Dept Publ Hlth, Yinchuan, Peoples R China
基金
中国国家自然科学基金;
关键词
Multidrug-resistant; Network meta-analysis; Standard precautions; Infection prevention and control (IPC); INTENSIVE-CARE UNITS; STAPHYLOCOCCUS-AUREUS; ANTIMICROBIAL RESISTANCE; ENTEROCOCCUS; PRECAUTIONS;
D O I
10.1007/s15010-025-02498-9
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
BackgroundThe effectiveness of infection prevention and control measures combating multidrug-resistant organisms (MDROs) in healthcare settings remains controversial.MethodsPubMed, Embase, MEDLINE, Cochrane Library, and CINAHL were searched from inception to June 1, 2024. The interventions encompassed standard precautions (SP), contact precautions (CP), hand hygiene (HH), environmental cleaning (ENV), antimicrobial stewardship programs (ASP), decolonization (DCL), and chlorhexidine baths (CHG). The primary outcome were the acquisition, infection, and colonization of MDROs. Secondary outcomes were all-cause mortality and MDROs-associated bacteraemia. Effect indicators were expressed as rate ratios (RRs) with 95% confidence intervals (CIs).ResultsThe study included a total of 97 articles, comprising 19 RCTs and 78 non-RCTs. The results showed that the most effective combination interventions for the acquisition, infection, and colonization of MDROs compared to SP varied as follows: CP + CHG (RR, 0.38 [0.18, 0.79]), SP + CP + ENV (RR, 0.04 [0.02, 0.08]), and SP + CHG (RR, 0.28 [0.14, 0.56]). In subgroup analyses, CP + CHG (RR, 0.36 [0.20,0.64]) was the most effective intervention for the acquisition of MDROs in the ICU setting, whereas SP + CP + ASP (RR, 0.35 [0.14,0.92]) was the most effective hospital-wide. Across subgroups, SP + CP + ENV (RR, 0.04 to 0.09 [95% CI, 0.01 to 0.99]) was identified as the most effective intervention for MDROs infections. In the ICU setting, SP + CHG (RR, 0.28 [0.14,0.56]) demonstrated the highest effectiveness in reducing the colonization of MDROs, whereas SP + CP + ENV + CHG (RR, 0.15 [0.06,0.38]) was the most effective on a hospital-wide scale. SP + CP + DCL (RR, 0.28 [0.24, 0.32]) was associated with reduced CRE colonization. The results of this study were robust according to the sensitivity analysis. None of the analyses related to secondary outcomes were statistically significant. In terms of article quality assessment, 94.7% of the RCTs were medium to high risk, while 92.31% of the non-RCTs. The primary limitation of the RCTs were related to the randomization process, whereas the non-RCTs were primarily affected by confounding bias.ConclusionsEffective interventions differ based on carriage status, intervention setting, and the resistant strain. Additionally, contact precautions is a crucial component of these combinations. Consequently, healthcare organizations can select appropriate interventions based on their unique resistance profiles to optimize precision and resource efficiency.
引用
收藏
页数:12
相关论文
共 50 条
  • [41] Comments on the published meta-analysis and systematic review of the prevalence of multidrug-resistant bacteria in Ethiopia
    Vaziri, Ali Zaman
    Shalchian, Armin
    Parto, Shima
    Sholeh, Mohammad
    JOURNAL OF GLOBAL ANTIMICROBIAL RESISTANCE, 2021, 27 : 156 - 156
  • [42] Prevalence of multidrug-resistant tuberculosis in Latin America and the Caribbean: a systematic review and meta-analysis
    Tengan, Fatima M.
    Figueiredo, Gerusa M.
    Leite, Olavo H. M.
    Nunes, Arielle K. S.
    Manchiero, Carol
    Dantas, Bianca P.
    Magri, Mariana C.
    Barone, Antonio A.
    Bernardo, Wanderley M.
    TROPICAL MEDICINE & INTERNATIONAL HEALTH, 2020, 25 (09) : 1065 - 1078
  • [43] Delamanid-containing regimens and multidrug-resistant tuberculosis: A systematic review and meta-analysis
    Nasiri, Mohammad Javad
    Zangiabadian, Moein
    Arabpour, Erfan
    Amini, Sirus
    Khalili, Farima
    Centis, Rosella
    D'Ambrosio, Lia
    Denholm, Justin T.
    Schaaf, H. Simon
    van den Boom, Martin
    Kurhasani, Xhevat
    Dalcolmo, Margareth Pretti
    Al-Abri, Seif
    Chakaya, Jeremiah
    Alffenaar, Jan-Willem
    Akkerman, Onno
    Silva, Denise Rossato
    Munoz-Torrico, Marcela
    Seaworth, Barbara
    Pontali, Emanuele
    Saderi, Laura
    Tiberi, Simon
    Zumla, Alimuddin
    Migliori, Giovanni Battista
    Sotgiu, Giovanni
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2022, 124 : S90 - S103
  • [44] Treatment outcomes among patients with multidrug-resistant tuberculosis: systematic review and meta-analysis
    Orenstein, Evan W.
    Basu, Sonjay
    Shah, N. Sarita
    Andrews, Jason R.
    Friedland, Gerald H.
    Moll, Anthony P.
    Gandhi, Neel R.
    Galvani, Alison P.
    LANCET INFECTIOUS DISEASES, 2009, 9 (03): : 153 - 161
  • [45] Adverse Events Associated With the Treatment of Multidrug-Resistant Tuberculosis: A Systematic Review and Meta-analysis
    Wu, Shanshan
    Zhang, Yuelun
    Sun, Feng
    Chen, Mingting
    Zhou, Lin
    Wang, Ni
    Zhan, Siyan
    AMERICAN JOURNAL OF THERAPEUTICS, 2016, 23 (02) : E521 - E530
  • [46] Prevention in adults of transmission of infection with multidrug-resistant organisms: an updated systematic review from Making Healthcare Safer IV
    McCarthy, Sean
    Motala, Aneesa
    Shekelle, Paul G.
    BMJ QUALITY & SAFETY, 2024,
  • [47] Gut colonization with multidrug resistant organisms in the intensive care unit: a systematic review and meta-analysis
    Heath, Madison R.
    Fan, Weijia
    Leu, Cheng-Shiun
    Gomez-Simmonds, Angela
    Lodise, Thomas
    Freedberg, Daniel E.
    CRITICAL CARE, 2024, 28 (01)
  • [48] Infection control and prevention measures to reduce the spread of vancomycin-resistant enterococci in hospitalized patients: a systematic review and meta-analysis
    De Angelis, Giulia
    Cataldo, Maria Adriana
    De Waure, Chiara
    Venturiello, Silvia
    La Torre, Giuseppe
    Cauda, Roberto
    Carmeli, Yehuda
    Tacconelli, Evelina
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2014, 69 (05) : 1185 - 1192
  • [49] Risk factors of multidrug-resistant bacteria infection in patients with ventilator-associated pneumonia: A systematic review and meta-analysis
    Hu, Jian-Nan
    Hu, Sheng-Qi
    Li, Zi-Ling
    Bao, Chen
    Liu, Qian
    Liu, Chao
    Xu, Shu-Yun
    JOURNAL OF INFECTION AND CHEMOTHERAPY, 2023, 29 (10) : 942 - 947
  • [50] Multidrug-resistant infection in COVID-19 patients: A meta-analysis
    Hu, Siqi
    You, Yao
    Zhang, Shenghui
    Tang, Jiake
    Chen, Chen
    Wen, Wen
    Wang, Chunyi
    Cheng, Yongran
    Zhou, Mengyun
    Feng, Zhanhui
    Tan, Tao
    Qi, Guanming
    Wang, Mingwei
    Liu, Xiaoyan
    JOURNAL OF INFECTION, 2023, 86 (01) : 73 - 75